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Objective: To assess the effects of mindfulness-based therapies (MBTs) on the outcomes of
people living with HIV.
Methods: During 2014, we searched the PubMed/MEDLINE, Embase, Web of Science,
Cochrane Library, and CBM databases to identify randomized and non-randomized
controlled studies which compared participants receiving mindfulness-based therapies
(MBTs), including mindfulness-based stress reduction (MBSR) and mindfulness-based
cognitive therapy (MBCT), with participants in control groups. The psychological,
biochemical, clinical, and behavioral outcomes of the study participants were analyzed.
Two separate reviewers independently performed the study selection, data extraction, and
quality assessment tasks, and a meta-analysis of selected studies was performed using
RevMan software.
Results: Seven articles describing results obtained with a total of 620 HIV-infected in-
dividuals enrolled in six randomized trials and one quasi-experimental trial were included
in the final meta-analysis. The overall methodological quality of the studies was moderate,
as most study criteria were unclear and subject to a high risk of bias. Patients receiving
MBT experienced significantly decreased feelings of stress after 8 weeks (p ¼ 0.03) of MBT,
and decreased feelings of depression after both 8 weeks (p ¼ 0.04) and 6 months (p ¼ 0.02).
Additionally, some patients receiving MBSR training or MBCT showed improved CD4þ
counts at 8 weeks and 6 months, respectively.
Conclusion: While MBT produced psychological benefits in HIV infected patients, any im-
provements in CD4þ counts were not robust. Additional studies with longer term follow-up
periods and larger sample sizes are required to ascertain the effectiveness of such
interventions.
Copyright © 2015, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).. Liu).
Nursing Association.
g Association. Production and hosting by Elsevier (Singapore) Pte Ltd. This is an open access
://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The development of combined antiretroviral therapy has
enabled HIV-infected individuals to live for longer periods of
time [1]. The WHO and UNAIDS estimated that 35 million
people world-wide were living with HIV at the end of 2013 [2].
The HIV virus infects activated CD4þ T lymphocytes, causing
their progressive depletion and subsequent defects in the
immune system that lead to various diseases and cancers [3].
In addition to producing physiological effects, the psycholog-
ical impact of having HIV/AIDS can affect disease progression
as well as a patient's clinical outcome [4]. A recent study [5]
reported a higher prevalence of psychological problems,
such as feelings of stress, depression, and anxiety, among
people living with HIV when compared to people in the gen-
eral population. This may be due not only to the illness, but(stress, anxiety, and depression) found among people living
with HIV have recently received greater attention by re-
searchers. These psychological problems might further sup-
press the immune system and accelerate disease progression,
causing an HIV-infected individual to develop AIDs more
quickly [6]. Furthermore, such psychological problems can
impair a patient's ability to understand and follow prescribed
treatment regimens, leading to poor cART adherence and
treatment results [7]. TheWHO has stated that enhancing and
preserving patient quality of life should be a primary outcome
goal of contemporary HIV therapy, and that new treatment
strategies should produce marked improvements in patient
health [8]. Therefore, equipping HIV infected patients with the
skills and coping strategies needed manage their physiolog-
ical and psychological problems has become an integral part
of providing comprehensive care to HIV/AIDS patients.
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psychology as practiced in the late 1970s. This type of therapy
seeks to have people live in the present moment, and be non-
judgmental, accepting, patient, open, curious, kind, and “non-
doing” [9]. It is hoped that through practicing mindfulness,
patientswill build the skills needed to pay total attention to the
present moment, and accept their physical pain or psycho-
logical distress with a non-judgmental awareness [10]. It has
been suggested that mindfulness exerts its effects via four
mechanisms: attention regulation, body awareness, emotion
regulation, andchanges inperspective regardingone's self [11].
Mindfulness-Based Stress Reduction (MBSR) andMindfulness-
Based Cognitive Therapy (MBCT) are two of the most widely
used mindfulness-based therapies, and are designed to pro-
vide therapeutic benefits to people who practice them [12].
MBSR therapy is a structured treatment program originally
developed to manage chronic pain, and is now widely used to
reduce the incidence and severity of psychologicalmorbidities
associated with chronic illnesses [9]. MBCT, combines ele-
ments of MBSR therapy, cognitive psychology, and cognitive-
behavioral therapy, and was initially designed to treat people
with a history of recurrent depression. It is currently used to
treat emotional and behavioral disorders [13].
The results of previous systematic reviews and meta-
analyses have suggested that MBSR training and MBCT
might be effective interventions for use in relieving chronic
pain [14,15], lowering blood pressure [16], as well as improving
psychological health (depression, stress, anxiety), and quality
of life [17e19]. The current systematic reviews concerning the
uses of MBSR training and MBCT have mainly focused on
studies involving patients with chronic diseases such as
cancer [19e24], chronic pain [14,25], psychiatric disorders
[17,18,26], cardiovascular diseases [16], and crowd diseases
[26e28]. Although the results of some clinical studies inves-
tigating the effects of MBSR training and MBCT on people
living with HIV have been reported, their findings have not
been widely publicized or acknowledged. Our current meta-
analysis was performed to assess the short- and long-term
effects of MBSR training and MBCT on people living with
AIDS, and compare those effects with those provided by
control interventions. Such information might provide evi-
dence regarding the usefulness of MBSR training and MBCT in
promoting the physical and mental health of people living
with HIV/AIDS.2. Methods
2.1. Eligibility criteria
Trials with the following characteristics were included in the
meta-analysis.
2.1.1. Types of study designs
Randomized controlled trials (RCTs) and quasi-experimental
trials.
2.1.2. Types of participants
Patients diagnosed as HIV-infected, regardless of age, infec-
tion duration or severity.2.1.3. Types of interventions
Eligible trials included those that compared patients receiving
MBSR training or MBCT with patients in either an inactive
control group (no treatment or standard care treatment) or
who were receiving some any other type of active treatment.
Studies describing interventions that were based on mind-
fulness, but were not specifically designated as an MBSR or
MBCT program, were excluded.
2.1.4. Types of outcomes
Primary outcomes: CD4þ cell counts, feelings of stress,
distress or depression in the physical and psychological as-
pects of life, respectively. Secondary outcomes: HIVeRNA
load, positive and negative effects of MBT on anxiety, mind-
fulness, physical symptomatology, mental health, results
shown on a checklist of side effects of HIV infection, and the
impact of those side effects on the patient's physical, psy-
chological, and clinical health. Patient behavioral outcomes
and the safety MBT were also assessed.
2.1.5. Length of follow-up
Both the short-term effects (determinations made ~8 weeks
after intervention) and long-term effects (determinations
made ~6 months after intervention) of MBT were analyzed.
2.2. Search strategy
We used both MeSH terms and free text terms to search the
following electronic databases without date restrictions:
PubMed/MEDLINE, Embase, Web of Science, the Cochrane Li-
brary, and CBM. We also retrieved references cited in the
included studies. Studies published in either Chinese or En-
glish were considered, and web sites such as http://
mindfulness teachers uk.org.uk and http://www.mindful
experience.org/ were searched to find gray literature.
The following strategy is an example of one used to elec-
tronically search the PubMed database: (HIV [MeSH Terms] OR
Human Immunodeficiency Virus [Title/Abstract] OR AIDS
Virus [Title/Abstract] OR Acquired Immunodeficiency Syn-
drome Virus [Title/Abstract]) AND (mind body therapies
[MeSH Terms] OR mindfulness [Title/Abstract] OR
Mindfulness-Based Stress Reduction [Title/Abstract] OR MBSR
[Title/Abstract] OR mindfulness based cognitive therapy
[Title/Abstract] OR MBCT [Title/Abstract]).
2.3. Study selection
After removing duplicated material, two authors indepen-
dently screened for titles of articles and abstracts of manu-
scripts which satisfied our eligibility criteria. Next, the full-
texts of manuscripts were checked to determine if they
described trials that should be included in this systematic
review. Disagreements between the two reviewers were
resolved by a third reviewer.
2.4. Data extraction
Each study's characteristics (participants, interventions, con-
trol conditions, outcome measures and findings) were
extracted independently by two different reviewers. The
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not available in their published manuscripts. A third inde-
pendent reviewer helped to resolve any disagreements.
2.5. Risk of bias
The Cochrane ‘risk of bias’ tool [29] was used to test for bias
and assess the methodological quality of each paper based on
six criteria: sequence generation, allocation concealment,
blinding of participants, personnel or outcome assessors,
completeness of outcome data, and selectivity of outcome
reporting. The degree to which a paper satisfied these criteria
was assessed by one reviewer, and checked by a second
reviewer. A third reviewer was invited to resolve any differ-
ences of opinion.
2.6. Data analysis and synthesis
The outcomes of studies were assessed using ReviewManager
software (Version 5.2, The Nordic Cochrane Centre, Copen-
hagen). For continuous outcomes, pooled effects were
assessed by calculating their standardized mean differences
(SMDs) with 95% confidence intervals (CIs). When two ormore
groups showed no statistically significant differences at
baseline, mean differences (SMDs) were calculated using the
final values for the particular outcomes (post-intervention
outcomes). When a significant difference existed between an
intervention and control group, the standardized mean dif-
ference (SMD) was calculated using the difference in the
changes in values frombaseline values. Themean changewas
obtained by subtracting the final mean value from the mean
value at baseline. Standard deviations (SDs) for statistical re-
sults were calculated using a formula in the Cochrane Hand-
book [30]. Correlations between baseline and follow-up values
were obtained from a comparable study or by using the cor-
relation coefficient (r ¼ 0.5) suggested in the Cochrane Hand-
book [29].
Statistical heterogeneity among the reviewed studies was
quantified by determining values for I2; where I2 < 30%,
I2 > 50%, and I2 > 75% were defined as moderate, substantial,
and considerable heterogeneity, respectively. To eliminate
clinical heterogeneity, we conducted subgroup analyses based
on the type of intervention (MBSR therapy or MBCT) and
control group used in various studies (active control group or
inactive group). Additionally, sensitivity analyses were per-
formed by excluding a single study and then comparing the
results of studies with a high risk for domain selection bias,
detection bias or attrition bias, with the results of studies
having a low risk for the selected particular bias. This type of
analysis allowed us to obtain more stable results.3. Results
3.1. Study selection
Our electronic search identified a total of 230 citations for re-
ports concerning either MBSR therapy or MBCT. After
excluding duplicates, 171 studies satisfied our eligibility re-
quirements, and full-text reports were obtained for 31 studies.Among those 31 studies, 24 did not fulfill our inclusion criteria
for one of the following reasons: they did not investigateMBSR
therapy or MBCT (n ¼ 14), or HIV-infected patients (n ¼ 6), or
did not include a control group (n ¼ 4). Finally, six randomized
controlled trials and one quasi-experimental study were
included in our meta-analysis [31e37]. No additional trial was
later included after retrieving references cited in the original
seven included studies. A flow chart describing our search
strategy and article retrieval results is shown in Fig. 1.
3.2. Study characteristics
The seven included studies (six randomized controlled trials
[31e36] and one quasi-experimental study [37]) were pub-
lished from 2003 to 2014 (Table 1), and were conducted in
Canada [33], Spain [37], Iran [35], and the USA [31,32,34,36],
respectively. The number of participants in the individual
studies ranged from 34 to 173, and a total 620 participants
were enrolled in all seven studies. All study participants had
been diagnosed as HIV/AIDS, and the experimental group in
each study received interventionwithMBCT orMBSR training.
Regarding control groups, three trials [32,35,36] incorporated
an active control treatment which was either a 1-day seminar
or Education and Support (ESC) meeting. The remaining four
studies [31,33,34,37] incorporated either a placebo group or
standard control group (TAU, routine follow-up, wait-list
control or comparison group). All study participants were
25e64 years old.
3.3. Intervention characteristics
MBSR training was used in six studies [31e36] and MBCT in
one study [37]. Both types of therapy were administered for
1.5e2.5 h/week during a program that lasted 8 or 10 weeks.
Additionally, the participants performed a daily homework
assignment which required 30e43 min of time each day, six
days per week. There was little variation among the in-
terventions used in the seven included studies.
3.4. Study quality (risk of bias)
We used the Cochrane risk of bias tool to assess the meth-
odological quality of five randomized controlled trials, and the
results are presented in Fig. 2. We found that two studies did
not report details of their randomization methods [32,35]. In
another study, a blinded design could not be used due to the
nature of MBT, and only one study reported that participants
were blinded to outcome assessments [32]. Five studies re-
ported unbalanced or unreasonable participant withdrawals,
and only two studies included an intention-to-treat analysis
[33,34]. Based on criteria in the Cochrane Handbook, we were
unable to assess our meta-analysis for publication bias
because there were <10 included studies.
3.5. Outcomes
The seven studies in our meta-analysis reported five types of
outcomes, which included psychological symptoms
(perceived stress [31,33,34], anxiety [33,37], depression
[33,34,37], mindfulness [34], positive-negative affect [34]),
Fig. 1 e Flow chart showing search results and article retrieval.
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life [37], clinical outcomes [35], and behavioral outcomes [37].
Additionally, the safety of MBT intervention was also
assessed.
3.5.1. Psychological outcomes
Four trials (with 216 participants receiving MBSR training in
three trials [31,33,34] and 39 participants receiving MBCT in
one trial [37]) used the perceived stress scale (PSS-10) to
examine the effects ofMBT on psychological stress (Figs. 3 and
4). Our meta-analysis analysis revealed a significant differ-
ence between an MBT group and a control group concerning
their levels of stress starting at 6 months (SMD ¼ 0.85, 95%
CI: 1.61 to 0.08, p ¼ 0.03). Moreover, a subgroup analysis
across different types of intervention also indicated thatMBSR
training could reduce patient stress after 6 months of practice
(SMD ¼ 0.41, 95% CI: 0.71 to 0.11, p ¼ 0.007). Additionally,
MBCT produced significant effects on stress in both the short-
(SMD ¼ 1.18, 95% CI: 1.86 to 0.49, p ¼ 0.0008) and long-
term (SMD ¼ 2.00, 95% CI: 2.84 to 1.17, p ¼ 0.000) time
frames.
Our meta-analysis of three RCTs (two using MBSR training
[33,34] and one using MBCT [37]) showed that MBT signifi-
cantly improved symptoms of depression in both the short-
term and long-term (SMD ¼ 0.35, 95% CI: 0.68 to 0.01,
p ¼ 0.04; SMD ¼ 0.47, 95% CI: 0.86 to 0.08, ¼ 0.02, respec-
tively). Furthermore, a subgroup analysis across interventions
showed that MBSR training produced a statistically significant
long-term effect (SMD ¼ 0.31, 95% CI: 0.61 to 0.01,
p ¼ 0.04). The study conducted by Gonzalez-Garcia showed
that MBCT had a positive effect on depression in both the
short-term and long-term (SMD ¼ 0.83, 95% CI: 1.49 to
0.17, p ¼ 0.01; SMD ¼ 1.02, 95% CI: 1.74 to 0.30, p ¼ 0.005,
respectively; Figs. 5 and 6). Two trials measured the effects ofMBT on patient anxiety using the Hospital Anxiety and
Depression Scale (HADS) [33] and the Beck Anxiety Inventory
(BAI) [37], respectively. The results showed that MBCT may
have had a slight long-term (6 months) effect on anxiety
(SMD¼0.74, 95%CI:1.43 to0.04). Previously, both Duncan
et al. [34] and Gayner et al. [33] used the Positive and Negative
Affect Schedule (PANAS) to analyze the positive and negative
effects of MBSR training. Our meta-analysis revealed that
MBSR had positive effects on people living with HIV after 6
months of training (SMD ¼ 0.42, 95% CI: 0.08e0.76, p ¼ 0.01).
Additionally, Duncan et al. [34] and Gayner et al. [33] used the
Five Factor Mindfulness Questionnaire (FFMQ) and The
MindfulnessMeasure (TMS), respectively, tomeasure changes
in mindfulness. Duncan et al. [34] reported on four factors
examined by the FFMQ, and Gayner et al. reported that par-
ticipants in an MBSR group experienced significantly
increased levels of mindfulness after 8-weeks of training
(SMD ¼ 1.16, 95% CI: 0.75e1.57, p ¼ 0.00) and also during a 6-
month follow-up period (SMD ¼ 0.75, 95% CI: 0.35e1.15,
p ¼ 0.00).
3.5.2. Biochemical outcomes
Three trials reported CD4þ cell counts for their participants.
Two of the trials used an active control design [32,35] and one
used an inactive control design [37]. The pooled results of
these two trials can be seen in Figs. 7 and 8. There was no
significant difference between the CD4þ counts of patients
who received MBT and control subjects at either an 8-week or
6-month time period. A subgroup analysis revealed an in-
crease in CD4þ cell counts only in the study conducted by
Gonzalez-Garcia et al. [37], and that increase occurred at 6
months (SMD ¼ 0.76, 95% CI: 0.07e1.46, p ¼ 0.03).
Two trials reported the effect of MBT on HIV RNA levels,
and neither study found any difference between experimental
Table 1 e Characteristics of the included studies.
Study Design Participants Interventions Controls Follow-up
(months)
Outcomes
and tools
Findings
Robinson et al.,
2003
USA
[31]
CCT 34 (32 males, 2 females), with a
mean age of 43.08 ± 6.07 years
in the MBI group and 36.10 ± 8.03
years in the control group
MBSR: 8 consecutive weekly
sessions, lasting 2.5 h each,
1 full-day (8 h) session, and
individual pre-test and
post program interviews;
daily practice  45 min
e ① Perceived stress: PSS;
② Mood States: POMS;
③ Functional assessment:
FAHI;
④ Immune response: NK
cell activity;
RANTES; SDF-1
⑤ Endocrine response:
DHEAS;
Cortisol;
Cortisol/DHEAS
① Significant differences be-
tween
groups regarding NK cell activity
and numbers at 8 weeks;
② No significant difference be-
tween groups regarding
perceived stress,
mood states, endocrine, or func-
tional health variables at 8
weeks.
Creswell et al.,
2009
USA
[32]
RCT 48 (43 males, 5 females), with a
mean age of 40 ± 9 years in the
MBI group and 42 ± 11 years in
the control group
MBSR: 8 weekly 2 h group
sessions, a day-long
retreat in the 7th week;
daily home mindfulness
meditation practice.
Control seminar:
1-day seminar
e ①CD4 cell counts and HIVe
RNA viral load;
② MBSR treatment
adherence;
① A significant difference be-
tween
groups regarding CD4 cell counts;
② No significant effects on HIV
RNA.
Gayner et al.,
2012
Canada
[33]
RCT 117 HIV gay men with an
age range of 25e64 years
MBSR consisting of eight
3-h weekly sessions
and a day-long retreat
with about an hour or
more of homework per
day, 6 days per week.
ATU 6 ①Distress: IES;
② Anxiety & depressive:
HADS,
③ Positive affect and nega-
tive
affects: PANAS;
④ Mindfulness: TMS
① A significant reduction in
scores
on the IES avoidance sub-scale;
② A significant difference be-
tween
groups in positive effects at 8
week
and 6 month follow-up
evaluations
③ No significant difference in
depression, anxiety, and the IES
intrusion sub-scale scores
between
groups;
④ A significant increase of
mindfulness among participants
in the intervention group at the
8-week and 6 month follow-up
evaluations.
Duncan et al.,
2012
USA
[34]
RCT 76 (64 males, 12 females), with a
mean age of 47.9 ± 6.8 years in
the MBI group and 48.2 ± 9.1 years
in the control group
MBSR: A standardized
series of 8 weekly
sessions of 2.5e3 h; daily
home assignments
of mindfulness practice
WLC 6 ①Side effects: AIDS Clinical
Trials Group symptom
checklist;
②Adherence to ART;
③ Depression: BDI
④ Perceived stress: PSS
⑤Positive and negative
affect: PANAS;
⑥Mindfulness: FFMQ
① MBSR reduced both the
frequency of symptoms attribut-
able
to ART and the distress related to
HIV side effects;
② No significant differences
between groups regarding
adherence, perceived stress,
depression, positive
and negative affect, and
mindfulness.
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SeyedAlinaghi
et al., 2012
Iran
[35]
RCT 171 (118 males, 53 females),
with a mean age of 34.7 ± 6.1
years in the MBI group and
45.6 ± 6.9 years in the control
group
MBSR is an eight-week
group-based course
in mindfulness meditation,
and is described in
the original MBSR manual
ESC 3, 6, 9, 12 ① CD4 count;
② Physical Symptom-
atology:
MSCL 37;
③Mental health: SCL-90R
① A significant difference in
CD4þ
counts between groups at 8
weeks,
3 months, 6 months and 9
months;
② A significant difference in
Physical Symptomatology be-
tween groups at 8 weeks, 3
months, 6 months, and 12
months;
③ A significant difference in the
mental health of groups at 8
weeks,
3 months, 6 months, 9 months,
and
12 months;
Weston et al.,
2012
USA
[36]
RCT 132 HIV þ adults (71 MBSR,
61 control) with CD4þ
counts > 250 cells/mL.
MBSR ESC 3, 12 High sensitivity C-reactive
protein (hsCRP); D-dimer
No effect on hsCRP or
D-dimer levels at 3 or 12 months
(p > 0.10)
Gonzalez-Garcia
et al., 2013
Spain
[37]
RCT 40 HIV infected participants
(20 males,
20 females), with a mean age
of 49.4 ± 5.1 years
MBCT: 2.5 h per week over
8 weeks A minimum of
45 min/day and 6 days/week
Routine 5 ① CD4 cell counts and HIV
e
RNA l load;
② Perceived stress: PSS-10;
③Depression: BDI-II
④Anxiety: BAI
⑤Quality of life: NHP;
⑥ Adherence to cART,
healthy diet, and smoking
secession;
① A significant difference be-
tween
groups regarding CD4 cell counts
at week 20.
② A significant difference be-
tween
groups regarding stress, depres-
sion,
anxiety, and quality of life at
weeks
8 and 20.
③ No significant difference be-
tween groups regarding the level
of HIVe
RNA, adherence to cART, eating a
healthy diet or smoking at weeks
8 and 20.
Note: Mindfulness-based Stress Reduction (MBSR); Mindfulness-based Cognitive Therapy (MBCT); Treatment-As-Usual (TAU); a wait-list control (WLC); antiretroviral therapy (ART); Education and
Support (ESC); The Impact of Event Scale (IES); The Hospital Anxiety and Depression Scale (HADS); The Positive and Negative Affect Schedule (PANAS); The Toronto Mindfulness Scale (TMS); Not-
tingham Health Profile (NHP); Perceived Stress Scale (PSS-10); Beck Depression Inventory (BDI-II); Beck Anxiety Inventory (BAI); Five Factor Mindfulness Questionnaire (FFMQ); The Medical Symptom
Checklist (MSCL (37)); The Symptom Checklist-90-Revised (SCL-90R (41)).
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Fig. 2 e Risk of bias for included studies.
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ally, Weston et al. [36] showed that MBSR training did not
affect the levels of high sensitivity C-reactive protein (hsCRP)
and D-dimer in participants at 3 and 12 months (p > 0.10
compared with the control group).
3.5.3. Quality of live, clinical outcomes, and behavioral
outcomes
A study by Gonzalez-Garcia et al. [37] revealed a significant
improvement in patient quality of life at both 8 weeks
(SMD ¼ 23.30, 95% CI: 37.67 to 8.93, p ¼ 0.001) and 20
weeks (SMD ¼ 32.7.30, 95% CI: 46.52 to 18.88, p ¼ 0.000).
Furthermore, Seyed Alinaghi et al. [35] reported significantly
enhanced physical and mental outcomes in a group of pa-
tients receiving MBSR training when compared with a group
receiving Education and Support (ESC); additionally, the
favorable effects were sustained for up to 12 months. How-
ever, that study found no significant difference between the
two groups regarding their behavioral outcomes asFig. 3 e Forest plot showing the short-term edemonstrated by cART adherence, eating a healthy diet, and
smoking after the intervention [37].
3.5.4. Safety
While no trial in our meta-analysis reported adverse events, a
total of 42 participants dropped out of studies due to dissat-
isfactionwith the program, health issues, emotional issues, or
the amount of time required and intensive nature of the
program.4. Discussion
4.1. Summary of main results
This is the first systematic review and meta-analysis to
examine the effects of MBSR training and MBCT on psycho-
logical outcomes, biochemical parameters, quality of life,
clinical outcomes, and behavioral outcomes, in HIV infected
patients. Our results indicate that MBT decreased the levels of
stress in patients at 8 weeks, and decreased symptoms of
depression at 8 weeks and 6 months.
4.2. Applicability of evidence
HIV infection is characterized by huge variability in the onset
age, a variety of clinical symptoms, and a long period of
illness. Additionally, HIV/AIDs patients often suffer from
serious physical and psychological conditions. The trials
included in our meta-analyses were conducted in both
developed and developing countries. Furthermore, they
enrolled both young and adult patients with a confirmed HIV
infection, as well as patients with different levels of disease
severity. Some of the patients were receiving antiretroviral
therapy, while others were not. Because our analysis included
awide range of populations, it could be argued that our results
apply to the majority of people living with HIV/AIDs.
4.3. Quality of evidence
This analysis included a small number of trials, and only one
trial reported the effect of MBCT on people infected with HIV.
This indicates that the use of mindfulness therapy in treatingffects of MBSR/MBCR on stress (8 weeks).
Fig. 5 e Forest plot showing effects of MBSR/MBCR on depression (8 weeks).
Fig. 4 e Forest plot showing the short-term effects of MBSR/MBCR on stress (6 months).
Fig. 6 e Forest plot showing effects of MBSR/MBCR on depression (6 months).
i n t e r n a t i o n a l j o u r n a l o f nu r s i n g s c i e n c e s 2 ( 2 0 1 5 ) 2 8 3e2 9 4 291HIV remains in an exploratory phase. Additionally, the overall
quality of evidence provided in the included studies was low,
and our results may have been affected by bias.
4.4. Agreement and disagreement with other systematic
reviews
Our findings regarding the ability of MBT to decrease stress in
HIV-infected patients on a long-term basis were in agreement
with findings in Chiesa and Serretti's study [26], which found
no significant difference in long-term stress reduction in
healthy individuals assigned to an MBT intervention group orcontrol group. However, another study [38] reported that MBT
had a small effect size (0.32) on reducing stress in adults with
chronic conditions. Reviews of studies conducted with cancer
patients suggested an even more significant effect of MBT on
patient stress (overall effect sizes of 0.58e0.71) [20,21].
Our results showed that MBT was marginally beneficial for
relieving symptoms of depression (SMDs ¼ 0.35 for 8 weeks
and 0.47 for 6 months), and this result was similar to previ-
ously reported findings [15,17]. Additionally, Strauss et al. [17]
reported findings that were consistent with ours from a sub-
group analysis conducted across MBCT and MBSR training. In
that subgroup analysis MBCT, but not MBST, was shown to be
Fig. 8 e Forest plot showing effects of MBI on CD4þ counts at 6 months.
Fig. 7 e Forest plot showing effects of MBI on CD4þ counts at 8 weeks.
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MBCT was found to be effective for reducing the incidence of
relapse among people who had experienced 3 episodes of
depression [39]. Our review provides additional evidence that
MBCT might also be effective in people with a current diag-
nosis of a depressive disorder.
Ourmeta-analysis included only a small number of studies
concerning the effect of MBT in treating anxiety, whichmakes
the findings less than robust. Our negative results regarding
the effects of MBT on anxiety were consistent with those re-
ported by both Strauss et al. [17] and Lakhan and Schofield
[15]. However, another previous meta-analysis found a mod-
erate to high effect size of anxiety among people with chronic
diseases, and also breast cancer patients (SMDs ¼ 0.47 and
0.51e0.73, respectively) [20,25,38].
Regarding biomedical outcomes, some previous studies
reported that MBSR training could increase plasma cortisol
levels, extend cell longevity [40,41], promote the recovery of
functional T cells [42], and improve plasma levels of IGF-1 and
antigen-specific IgM and IgG 3 [43]. These results compliment
our finding regarding the effect of MBT on CD4þ counts.
Additionally, two pilot trials [45,46] reported that MBSR ther-
apy significantly improved both the CD4þ counts and psy-
chological status of people living with HIV. MBSR training not
only improved the attitudes (less negativity) of the patients,
but also decreased their degrees of reactivity and impulsivity,improved their levels of self-care, and increased their
perceived value of socializing with other people. Finally, Gal-
legos et al. [44] recently reported that MBSR training might
benefit the hypothalamicepituitaryeadrenal (HPA) axis and
improve the emotional outcomes of older adults.5. Limitations
Our meta-analysis has some limitations that should be
mentioned. The first limitation concerns the experiment
design; as only three studies [32,35,36] included an active
control group and the other four studies had an inactive
control group [31,33,34,37]. Future studies should include an
active control therapy to better demonstrate the benefits of
MBT. Second, the studies in our meta-analysis were of only of
moderate methodological quality, because their criteria were
unclear, and their design permitted a high risk of bias, which
inevitably affected the results of our analysis. Third, four
studies only used only sixmonths as a cut-off time for judging
the long-term effects of therapy, while one trial used a 12
month time period for this purpose. For people living with HIV
and experiencing a current episode of physical or mental
disorders, a considerably longer followup period would allow
for a more precise evaluation of the long-term effects of a
therapy. Fourth, although we used a comprehensive search
i n t e r n a t i o n a l j o u r n a l o f nu r s i n g s c i e n c e s 2 ( 2 0 1 5 ) 2 8 3e2 9 4 293strategy to retrieve existing trials, due to language and other
limitations, only seven studies were included in our analysis,
and this might have influenced the robustness of our evi-
dence. Lastly, due to geographical and cultural differences, the
results of the included studiesmight not be directly applicable
to Chinese HIV/AIDS patients; therefore, clinical practitioners
should consider racial and cultural differences when
attempting to apply our results.6. Implications for further research
Reich et al. [47] reported that the baseline biomarkers of study
participants can influence the benefits they receive from
MBSR training, and that adherence to an intervention protocol
is also a key factor for ensuring that patients benefit from
MBSR therapy [36,48]. Although our meta-analysis contained
no information regarding protocol adherence, our findings
clearly showed thatMBTwasmore effective for treating stress
and depression than for treating anxiety. Therefore, we
caution against offering MBT as a first line intervention to
people experiencing a primary anxiety disorder. Additionally,
MBCTwas better thanMBSR therapy for improving symptoms
of depression among people living with HIV, indicating that
intervention methods should be carefully selected and based
on specific symptoms exhibited by a patient.7. Conclusions
This systematic review showed that MBT had a long-term
effect on stress and both a short- and long-term effect on
depression in people living with an HIV infection. Our results
concerning the effects of MBT on anxiety and CD4þ counts in
intervention and control groups were ambiguous. More robust
studies with longer follow-up times are required to establish
the actual efficacy of MBT intervention in HIV/AIDS patients.Author contributions
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